No abstract available.
Antibodies, Monoclonal* ; Chlamydia trachomatis* ; Chlamydia*

No abstract available.
Cervix Uteri* ; Chlamydia trachomatis* ; Chlamydia* ; Female

338 subjects at the age of 17-49 were undergone EIA test. Results showed an increasing trend in Chlamydia trachomatis infection. Clinical manifestations were not detected. The incidence is highest at the age of 17-26 (14.68%), 17-36 (10.67%). In the groups of genital tract inflamation, of uterine neck, of vaginitis the incidence reaches 2.7%, 12.71% and 12.50% respectively
Chlamydia trachomatis ; Immunoenzyme Techniques ; Women

Chlamydia trachomatis has been shown to induce reactive arthritis in people, especially after sexually acquired genitourinary infection. To determine the connection between Chlamydia trachomatis with reactive arthritis, in this study we examined antigen Chlamydia trachomatis lipopolysarcaride. Antibody IgG, and DNA of chlamydia trachomatis were investigated in samples (urine, serum, and synovial fluid) from 52 patients were diagnosed and treated in Rheumatology Department, Bach Mai Hospital from August 2001 to August 2003. As results we found that 38.5% urine samples positve with antigen LPS. Antibody IgG positive in 44.2% of serum samples and in 34.6% of synovial fluid samples. Special DNA of Chlamydia trachomatis was detected in 53.2% of synovial fluid samples and in 42.2% of urine samples positive. This results will contribute to determine the role of DNA-Chlamydia trachomatis in reactive arthritis diagnosis.
Chlamydia trachomatis, Diagnosis , Arthritis, Polymerase Chain Reaction

Chlamydia trachomatis is known as a major causative microorganism in non-gonococcal urethritis(NGU) in men. We examined two kinds of specimens simultaneously, endourethral swab and urine, in each patient to determine the reliability of these two different specimens for the detection of the Chlamydia trachomatis antigen in male NGU patients using ELISA method. Tota1 273 patients entered this study were divided into two groups according to sampling order of urine and endourethral swab. In group A(141 patients), we took endourethral swab first, then first portion of voided urine was caught. In group B(132 patients), endourethral swab was performed after urine sampling. Twenty five out of 273 patients(9.2%) showed Chlamydia trachomatis antigen positive in endourethral swab sample and 1 out of 273 patients(0.4%) was positive in urine sample. There was no significant difference of antigen positive rate of endourethral swab examination between group A and group B. Our data suggest that examination of endourethral swab is more reliable method for the detection of the Chlamydia trachomatis antigen than urine examination in male NGU patient.
Chlamydia trachomatis* ; Chlamydia* ; Enzyme-Linked Immunosorbent Assay ; Humans ; Male

Possible role of chlamydia trachomatis (C. trachomatis) in non-gonococcal Urethritis and chronic prostatitis was investigated by enzyme immunoassay technique in a study of 85 cases of non-gonococcal urethritis and 23 chronic prostatitis cases. 1. C. trachomatis was detected from 21 (24.7%) of 85 non-gonococcal urethritis patients and third decade represented the highest positive rate. 2. C. trachomatis was detected from 5 cases (21.7%) of 23 chronic prostatitis patients. 3. A significantly higher positive C. trachomatis detection rate of 60. 7% was obtained from those with a profuse urethral discharge compared with those with a scanty discharge. 4. A significantly higher positive C. trachomatis detection rate of 52.3% was obtained from cases with no previous history of urethritis compared with those who had previous history of urethritis in 85 cases of non-gonococcal urethritis.
Chlamydia trachomatis* ; Chlamydia* ; Humans ; Immunoenzyme Techniques* ; Prostatitis* ; Urethritis*

No abstract available.
Antibodies* ; Chlamydia trachomatis* ; Chlamydia* ; Humans ; Neisseria gonorrhoeae* ; Neisseria* ; Prevalence*

No abstract available.
Antibodies* ; Chlamydia trachomatis* ; Chlamydia* ; Humans ; Neisseria gonorrhoeae* ; Neisseria* ; Prevalence*

No abstract available.
Chlamydia trachomatis* ; Chlamydia* ; Doxycycline* ; Enoxacin* ; Erythromycin* ; Pipemidic Acid*

No abstract available.
Chlamydia trachomatis* ; Chlamydia* ; Doxycycline* ; Enoxacin* ; Erythromycin* ; Pipemidic Acid*